It was first proposed that cyclic ADP-ribose (cADPR) could activate ryanodine receptors (RyR) in 1991. Following a subsequent report that cADPR could activate cardiac RyR (RyR2) reconstituted into artificial membranes and stimulate Ca 2+-release from isolated cardiac SR, there has been a steadily mounting stockpile of publications proclaiming the physiological and pathophysiological importance of cADPR in the cardiovascular system. It was only 2 years earlier, in 1989, that cADPR was first identified as the active metabolite of nicotinamide adenine dinucleotide (NAD), responsible for triggering the release of Ca 2+ from crude homogenates of sea urchin eggs. Twenty years later, can we boast of being any closer to unraveling the mechanisms by which cADPR modulates intracellular Ca 2+-release? This review sets out to examine the mechanisms underlying the effects of cADPR and ask whether cADPR is an important signaling molecule in the heart. © 2010 Blackwell Publishing Ltd.
CITATION STYLE
Venturi, E., Pitt, S., Galfré, E., & Sitsapesan, R. (2012, April). From Eggs to Hearts: What Is the Link between Cyclic ADP-Ribose and Ryanodine Receptors? Cardiovascular Therapeutics. https://doi.org/10.1111/j.1755-5922.2010.00236.x
Mendeley helps you to discover research relevant for your work.